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hank proteins, initially also described as ProSAP
proteins, are scaffolding adaptors that have been
previously shown to integrate neurotransmitter re-
ceptors into the cortical cytoskeleton at postsynaptic
densities. We show here that Shank proteins are also crucial
in receptor tyrosine kinase signaling. The PDZ domain–
containing Shank3 protein was found to represent a
novel interaction partner of the receptor tyrosine kinase
Ret, which binds specifically to a PDZ-binding motif
present in the Ret9 but not in the Ret51 isoform. Further-
more, we show that Ret9 but not Ret51 induces epithelial
S
 
cells to form branched tubular structures in three-dimen-
sional cultures in a Shank3-dependent manner. Ret9 but
not Ret51 has been previously shown to be required for
kidney development. Shank3 protein mediates sustained
Erk–MAPK and PI3K signaling, which is crucial for tubule
formation, through recruitment of the adaptor protein
Grb2. These results demonstrate that the Shank3 adaptor
protein can mediate cellular signaling, and provide a
molecular mechanism for the biological divergence be-
tween the Ret9 and Ret51 isoform.
 
Introduction
 
The Shank family of neuronal scaffolding proteins consist of
three family members, Shank1 to 3, which harbor multiple
protein–protein interaction sites such as ankyrin repeats, SH3,
PDZ, and SAM motifs, and multiple proline-rich regions
(Boeckers et al., 1999, 2002; Naisbitt et al., 1999; Tu et al.,
1999; Yao et al., 1999; Sheng and Kim, 2000). Shank proteins
are cytoplasmic and have been shown to function in the forma-
tion and maintenance of postsynaptic densities by integrating
neurotransmitter receptors, like AMPA, NMDA and glutamate
receptors, into the cortical cytoskeleton. They bind effector
proteins such as PIX, IRSp53, and cortactin, which modulate
signaling of small G proteins and actin assembly (Du et al.,
1998; Naisbitt et al., 1999; Bockmann et al., 2002; Soltau et al.,
2002; Park et al., 2003), but they are also connected to the actin
cytoskeleton by interaction with 
 

 
-fodrin (Bockers et al., 2001)
and the actin-binding protein Abp1, which can be recruited to
dendritic spines in a Shank-dependent manner (Qualmann et
al., 2004). Shank proteins also link cell surface receptors to
intracellular calcium stores by interaction with the scaffolding
protein Homer (Tu et al., 1999; Sala et al., 2001). The so far–
described protein–protein interactions suggest that Shanks act
mainly as dynamic cytoskeletal adaptors in neurons and do not
play an active role in signal transduction. A function of Shank
proteins in nonneuronal cells has not been described.
The Ret receptor tyrosine kinase is crucial for develop-
ment of enteric nervous system and mammalian kidney, as
targeted deletion of Ret in mice leads to loss of enteric ganglia
and severe kidney hypodysplasia or aplasia caused by a failure
of ureteric bud outgrowth (Romeo et al., 1994; Schuchardt et al.,
1994; Smith et al., 1994). Tubular outgrowth of the ureteric bud
epithelium is regulated by signals emanating from surrounding
metanephric mesenchyme (Saxen and Sariola, 1987; Sariola
and Sainio, 1997), e.g., glial cell line–derived neurotrophic factor
(GDNF). GDNF activates Ret at the tips of ureteric bud epithelia
(Sanchez et al., 1996; Enomoto et al., 1998; Baloh et al., 2000;
Vainio and Lin, 2002), where Ret is expressed in two major
splice variants, Ret9 and Ret51, which differ only in their
COOH-terminal amino acids (Tahira et al., 1990). Ret9 is of
particular importance for both kidney and enteric nervous
system development, as severe kidney agenesis and loss of
 
J. Grimm’s present address is Rinat Neuroscience Corporation, Palo Alto,
CA 94304.
Correspondence to W. Birchmeier: wbirch@mdc-berlin.de
Abbreviations used in this paper: GDNF, glial cell line-derived neurotrophic factor;
HGF/SF, hepatocyte growth factor/scatter factor; MEN, multiple endocrine neo-
plasia; PI3K, phosphatidylinositol-3-kinase; sGFR
 

 
1, soluble coreceptor GFR
 

 
1.
 o
n
 April 22, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 JCB • VOLUME 167 • NUMBER 5 • 2004946
 
enteric ganglia of Ret-null mutant mice can be rescued through
reexpression of Ret9, but not of Ret51 (Srinivas et al., 1999; de
Graaff et al., 2001). Gain-of-function mutations of Ret in hu-
man patients are associated with various inherited cancer syn-
dromes leading to neuroendocrine tumor formation, such as
multiple endocrine neoplasia (MEN 2A and MEN 2B) and fa-
milial medullary thyroid carcinoma (Jhiang, 2000). Patients
with MEN 2A and MEN 2B mutations also show renal dyspla-
sia (Lore et al., 2000, 2001; McIntyre et al., 2003).
Activation of Ret by GDNF in the presence of its cognate
coreceptor, GFR
 

 
1, leads to autophosphorylation of tyrosine res-
idues in the cytoplasmic domain of Ret and subsequent recruit-
ment of signaling mediators such as PLC
 

 
 and the adaptor pro-
teins Grb2, Shc, FRS-2, and dok1-5 (Borrello et al., 1996; Arighi
et al., 1997; Alberti et al., 1998; Grimm et al., 2001; Kurokawa et
al., 2001). Grb2 can recruit Sos and signaling complexes medi-
ated by the Gab adaptor proteins, containing the tyrosine phos-
phatase SHP-2 and phosphatidylinositol-3-kinase (PI3K; Hayashi
et al., 2000). These adaptors interact with either of the two Ret
isoforms. Binding of adaptor proteins to Ret9 and Ret51 leads to
activation of the Erk–MAPK and PI3K pathways (van Weering
and Bos, 1998) as well as to cytoskeletal reorganization through
activation of Rac (Fukuda et al., 2002). However, the signaling
mechanisms that underlie the functional differences between Ret9
and Ret51 during embryonic development remained unclear.
We have here identified a new signaling complex of the
Ret tyrosine kinase, involving the Shank family of neuronal
adaptors. Complex formation depends on the direct interaction
of the Shank3 PDZ domain with a novel PDZ-binding motif in
the Ret9 isoform. This complex mediates tubulogenesis of kid-
ney epithelial cells in vitro, which mimics ureteric bud branch-
ing during kidney development (Sachs et al., 1996; Pollack et al.,
1998). By recruiting further signaling mediators, Shank3 induces
sustained signaling by the Erk–MAPK and PI3K pathways. Our
findings reveal a novel function for Shank proteins in signal
transduction of tyrosine kinase receptors, and provide a molecu-
lar mechanism for the divergent functions of Ret9 and Ret51.
 
Results
 
Identification of Shank proteins as Ret 
interaction partners
 
The protooncogene Ret is expressed in two splice variants,
Ret9 and Ret51, which differ only in carboxyl-terminal resi-
dues. 9 additional amino acids are present in Ret9; 51 entirely
different amino acids in Ret51 (Fig. 1 a). To identify signaling
effectors downstream of the functionally essential Ret9 iso-
form, we performed yeast two-hybrid screens with the entire
cytoplasmic domain of Ret9 as a bait against a mouse em-
bryonic cDNA library (Weidner et al., 1996). From these
screens, we isolated cDNA clones encoding the PDZ domain of
Shank3, e.g., amino acids 588–741 (Fig. 1 b). Shank proteins
are scaffolding adaptors, which contain several domains such
as ankyrin repeats, SH3, PDZ, and SAM domains, and multiple
proline-rich regions (Boeckers et al., 1999; Naisbitt et al.,
1999; Tu et al., 1999; Yao et al., 1999). The Shank3 PDZ do-
main binds exclusively to Ret9 and not to Ret51, as shown by
yeast two-hybrid analysis (Fig. 1 c). Upon sequence analysis,
we observed that Ret9, but not Ret51, harbors a putative PDZ-
binding motif (FTRF) at the very COOH terminus (Fig. 1 a).
Deletion of this motif (Ret9 
 

 
4) or mutation of the crucial
COOH-terminal phenylalanine to alanine (Ret9 FA; Borg et
al., 2000) prevents interaction with Shank3 (Fig. 1, a and c),
demonstrating that Shank3 interacts with Ret9 through the
newly identified PDZ-binding motif.
We confirmed this interaction by coimmunoprecipitation
of Ret9 with the PDZ domain of Shank3 in HEK293 cells. In-
deed, only Ret9 containing an intact PDZ-binding motif, and
not Ret9 FA or Ret51, could be coimmunoprecipitated with the
Shank3 PDZ domain (Fig. 1 d). Furthermore, Shank3 binding
could be reconstituted by fusion of the Ret9 PDZ-binding motif
to the COOH terminus of Ret51 (Ret51-9; Fig. 1, a and d). As
expected, this interaction is not dependent on tyrosine phos-
phorylation of Ret, as Shank still binds to a kinase-dead Ret9
mutant (unpublished results). These results demonstrate that
Figure 1. Ret9 interacts with the Shank3 PDZ domain.
(a) Schematic representation of Ret9, Ret51, and of
COOH-terminal mutants. Cad, cadherin domain; Tm,
transmembrane domain; Tk, tyrosine kinase domain; Ret9
4, deletion of the PDZ-binding motif; Ret9 FA point muta-
tion in the PDZ-binding motif; Ret51-9, Ret9 PDZ-binding
motif attached to Ret51. (b) Domain structure of Shank3
and Shank3 deletion mutants. Ank, ankyrin repeats; SH3,
src homology 3 domain; Pro, proline-rich region; SAM,
sterile alpha motif. (c) Interaction of Ret9 and Shank3 in
a yeast two-hybrid analysis. Binding of the GAL4-binding
domain–Shank3 PDZ domain fusion protein (or of the
GAL4-binding domain alone) to GAL4-activation domain
fusion proteins of the cytoplasmic domains of Ret9,
Ret51, Ret9 4, and Ret9 FA was tested. Growth of yeast
on selective medium is shown. (d) Interaction of Ret9 and
Shank3 in mammalian cells. HEK293 cells were cotrans-
fected with the indicated Ret mutants and Flag-tagged
Shank3–PDZ. Coimmunoprecipitation with Flag–M2 Seph-
arose was performed followed by SDS-PAGE and West-
ern blotting with the indicated antibodies.
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the Shank3 protein forms a specific complex with the Ret9 iso-
form through a novel Ret9 PDZ-binding motif.
To confirm that the Shank–Ret9 interaction is direct, we
performed a PDZ class switch experiment (Kaech et al., 1998)
by introducing compensatory mutations in Shank3 and Ret9.
PDZ domains can be subdivided by their ability to bind to dif-
ferent receptor tails (Songyang et al., 1997; Vaccaro and Dente,
2002). Shank3 harbors a type I PDZ domain characterized by
the presence of a histidine residue at position 716 (Fig. 2 a).
Ret9 contains a type I PDZ-binding motif characterized by a
threonine residue at position 1070. Mutation of the critical his-
tidine residue to valine converts the Shank3 PDZ domain to a
class II domain (Shank3–PDZ HV), which no longer binds to
Ret9 (Fig. 2 b). Introduction of a compensatory mutation in
Ret9 (threonine 1070 to tyrosine, Ret9 TY) converts the PDZ-
binding motif into a type II–binding motif and reconstitutes the
Shank3–Ret9 interaction (Fig. 2 b). These data demonstrate
that Ret9 and Shank3 interact in a PDZ domain–mediated fash-
ion, and that this interaction is direct.
Both Ret and Shank2 have been reported to localize to the
renal tubular system (Pachnis et al., 1993; Redecker et al., 2001).
Using immunohistochemistry with a specific antibody, we could
show that Shank3 localizes to basolateral cell membranes in epi-
thelial tubules of the developing kidney in E16.5 mouse embryos
(Fig. 3, a and b). No expression of Shank was observed in sur-
rounding mesenchymal cells. Strong staining was also observed
at apical sites of renal tubules, which may indicate a further scaf-
folding function of Shank proteins. We could also demonstrate
interaction of endogenous Ret9 with Shank3 in lysates of mouse
kidneys by coimmunoprecipitation (Fig. 3 c). Taken together,
our data indicate that Ret and Shank3 interact in the kidney in
vivo, and that Shank3 is expressed at sites of Ret function.
 
Ret9, but not Ret51, induces epithelial 
tube formation
 
In vivo experiments have indicated that only Ret9 is crucial for
kidney development (Srinivas et al., 1999; de Graaff et al.,
2001). Here we have used an in vitro tubulogenesis assay with
MDCK kidney epithelial cells to mimic the formation of kid-
ney tubules (Montesano et al., 1991; Santos and Nigam, 1993;
Weidner et al., 1993). MDCK cells seeded in a three-dimen-
sional collagen matrix form cysts, consisting of a single polar-
ized epithelial cell layer enclosing a fluid-filled lumen. Stimu-
lation with growth factors such as hepatocyte growth factor/
scatter factor
 
 (
 
HGF/SF) induces the reorganization and growth
of these cysts into branched, hollow tubes, which invade the
surrounding matrix. We have generated MDCK cell lines that
express various forms of Ret and stimulated these with the Ret
ligand GDNF and the essential soluble coreceptor GFR
 

 
1
(sGFR
 

 
1; Paratcha et al., 2001). We found that cells express-
ing Ret9, but not Ret51, respond to ligand stimulation and form
tubules (Fig. 4, a, b, d, and e). Remarkably, mutation of the
PDZ-binding motif in Ret9 (Ret9 FA) prevented tubule forma-
tion (Fig. 4, g and h). In contrast, cells expressing the Ret51-9
protein, where the Ret9 PDZ-binding motif is attached, are ca-
pable of undergoing tubule formation (Fig. 4, j and k). Parental
MDCK cells, which do not express endogenous Ret, do not re-
spond to stimulation with GDNF–sGFR
 

 
1 (Fig. 4, m and n).
As a further control, addition of HGF/SF leads to tubulogene-
sis in all cell lines (Fig 4, HGF/SF column). The expression of
the various Ret constructs and of endogenous Shank3 in the
MDCK cell lines is shown by RT-PCR (Fig. 4, p and q). These
data demonstrate that signaling by the Ret9 isoform is suffi-
cient to induce epithelial tube formation, and that this activity
depends on an intact PDZ-binding motif on Ret.
Figure 2. PDZ class-switch experiment. (a) Schematic
representation of the PDZ class-switch mutants in Ret9 and
Shank3. (b) Coimmunoprecipitation of Ret9 and Shank3
and their mutants. Flag-tagged Shank3–PDZ and Myc-
tagged Ret9 were coexpressed in HEK293 cells, and
Shank3–PDZ was precipitated using Flag–M2 Sepharose
followed by SDS-PAGE and Western blotting with anti-
Myc or anti-Flag tag antibodies. The Ret PDZ-binding class
and the Shank3 PDZ domain class are indicated.
Figure 3. Ret9 interacts with Shank3 in vivo. (a and b)
Immunofluorescence for Shank3 of embryonic kidney sec-
tions. Frozen sections of E16.5 mouse embryos were
stained for Shank3 in green and DNA in blue. The dashed
lines in b outline epithelial tubules. (c) Coimmunoprecipita-
tion of Ret9 with Shank3 from lysates of mouse kidneys.
Immunoprecipitations were subjected to SDS-PAGE and
Western blotting. The Western blot was developed using
antibodies against Ret9 and Shank3 as indicated. Con-
trols were an immunoprecipitation with a control anti-
body, whole cell lysate from mouse kidneys, and whole
cell lysate from Neuro-2A cells (mouse neuroblastoma
2A), which are rich in Ret9 and Shank3. Bars: 50 m.
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Shank3 binding is crucial for Ret9-
induced tube formation
 
The PDZ-binding motif of Ret9 is also required for Shank3
binding. To analyze whether Shank proteins indeed mediate
tube formation, we fused distinct fragments of Shank3 to Ret9
and examined the hybrids in the biological assays. It should be
noted that fusing any sequence to the COOH terminus of Ret9
abrogates PDZ binding (Songyang et al., 1997) and tubule for-
mation (unpublished results). However, by attachment of the
proline-rich domain of Shank3 to Ret9 (Ret9–Shank3–Pro1), we
could reconstitute tube formation (Fig. 5, d and e). A fusion con-
struct of Ret with a shorter fragment of the proline-rich region of
Shank3 (Shank3-Pro2, aa 632–1057; Fig. 1 b) did also induce
tubule formation (see Fig. 8, a and b). Fusion of other domains
of Shank3 to Ret9, e.g., the ankyrin repeat and the SH3 domains,
are not sufficient to induce tubulogenesis (Ret9–Shank3–NT;
Fig. 5, a and b). Expression of Ret9–Shank3–NT and Ret9–
Shank3–Pro1 is shown by RT-PCR (Fig. 5 g). Again, all cell
lines were responsive to HGF/SF (Fig. 5, c and f). We could not
obtain expression of a fusion construct between Ret and full-size
Shank3. These results indicate that Shank3 can indeed act down-
stream of Ret9 to stimulate the formation of epithelial tubes.
This activity is mediated by the proline-rich domain of Shank3.
 
The Ret9–Shank3 interaction facilitates 
sustained Erk–MAPK and PI3K signaling
 
Tubulogenesis by HGF/SF and Met has been shown to require
sustained activation of the Erk–MAPK and PI3K pathways
(Khwaja et al., 1998; Maroun et al., 2000; Schaeper et al.,
2000). Previous investigations have shown that these pathways
are also activated by Ret9 and Ret51 (van Puijenbroek et al.,
1997; Besset et al., 2000; Hayashi et al., 2000; Melillo et al.,
2001; Pelicci et al., 2002). Here we have addressed the ques-
tion whether activation of the Erk–MAPK and PI3K pathways
is modulated by the Ret9 PDZ-binding motif and Shank3 inter-
action, using the MDCK cell lines described above. Activation
of Erk1/2, as measured by phosphorylation, is induced 10 min
after GDNF–sGFR
 

 
1 stimulation of Ret9-expressing cells, and
remains sustained for at least 8 h (Fig. 6 a). Maximal phosphor-
ylation of PKB–Akt, as indicator of activation of the PI3K
pathway, in Ret9-expressing cells occurs at 30 min after stimu-
lation, and also remains sustained for at least 8 h (Fig. 6e).
However, mutation of the Ret9 PDZ-binding motif (Ret9 FA)
prevents sustained but not transient activation of Erk1/2 and
activation of PKB–Akt (Fig. 6, b and f). Stimulation of Ret51-
expressing cells also fail to induce sustained activation of Erk–
MAPK and cannot activate PKB–Akt (Fig. 6, c and g). MDCK
cells expressing the proline-rich domain of Shank3 fused to Ret
(Ret–Shank3–Pro1), but not other Ret–Shank3 fusion proteins,
exhibit sustained Erk–MAPK and PI3K activation similar to
Ret9 (unpublished results).
Taken together, our results indicate that Shank3 functions
downstream of Ret9 to enable sustained Erk–MAPK and PI3K
signaling and the formation of epithelial tubules. These effects
are mediated by the central proline-rich domain of Shank3.
 
Shank3 interacts with the adaptor 
protein Grb2, which mediates sustained 
Erk–MAPKand PI3K signaling and 
epithelial tube formation
 
Several adaptor molecules such as Shc, Grb2, FRS2, and dok4/5
are known to be involved in stimulation of the Erk–MAPK
pathway downstream of Ret and are recruited to the plasma
membrane (Borrello et al., 1996; Arighi et al., 1997; Alberti et
al., 1998; Grimm et al., 2001; Kurokawa et al., 2001). Analysis
of the Shank3–Pro2 sequence revealed a potential binding site
Figure 4. Induction of tubular structures by Ret depends on the PDZ-
binding motif. MDCK cell lines expressing Ret9 (a–c), Ret51 (d–f), Ret9 FA
(g–i), Ret51-9 (j–l), or control cells without Ret (m–o) were seeded as single
cell suspensions into three-dimensional collagen matrices and stimulated
with GDNF–sGFR1 or HGF/SF. Photographs were taken after fixation.
Bar in o: 200 m (applies to a–o). (p) Expression of the Ret cDNA con-
structs in the various MDCK cell lines is shown by RT-PCR. (q) Expression of
endogenous Shank3 in mouse brain and MDCK cells is shown by RT–PCR.
Figure 5. The Shank3 proline-rich domain is crucial for
Ret-induced tubule formation. MDCK cell lines expressing
fusion proteins of the full-length Ret9 receptor with either
the NH2 terminus of Shank3 (Ret–Shank3 NT; a–c) or the
proline-rich domain of Shank3 (Ret9–Shank3–Pro1; d–f)
were examined for tubulogenesis in three-dimensional
collagen matrices. After stimulation with GDNF–sGFR1
or HGF/SF, cell cultures were fixed and photographed.
Bar in f: 200 m (applies to a–f). (g) Expression of the
indicated cDNA constructs shown by RT-PCR.
 o
n
 April 22, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
 SHANK/PROSAP SCAFFOLD PROTEINS IN RET SIGNALING • SHUETZ ET AL.
 
949
 
for the Grb2 SH2 domain, with the consensus sequence
pYXNX. Indeed, endogenous Grb2 was recruited to this bind-
ing site, as shown by coimmunoprecipitation of Shank3–Pro2
upon coexpression of Ret9 (Fig. 7 b). Coexpression of the
PDZ-binding motif mutant Ret9 FA did not allow binding of
Grb2 to Shank3–Pro2. Moreover, coexpression of Ret9 leads to
significantly higher levels of Shank3 phosphorylation than Ret9
FA. We determined that Grb2 is not complexed indirectly with
Ret9 through Shc, because Shank3–Pro2 still binds Grb2 when
the Shc-binding–deficient Ret9 Y1062F mutant is coexpressed
(Fig. 7, a and b). Finally, we mutated tyrosine 1006 to phenyl-
alanine in the Grb2-binding site of Shank3 (Shank3–Pro1 Y1006F),
which does not interact with Grb2 (Fig. 7, a and b).
Mutation of the Grb2-binding site of Shank3 in our Ret9
receptor hybrid prevented tubule formation (Fig. 8). These re-
sults show that Shank3 recruits Grb2 protein to Ret9 receptor
complexes in a phosphorylation-dependent manner, and that
this interaction is functionally relevant. Two other signaling ef-
fectors are also known to bind to Shank3–Pro2: the Rho family
GDP–GTP exchange factor PIX, which binds to the PDZ do-
main (aa 654–739; Park et al., 2003), and the actin polymeriza-
tion regulator IRSp53, which binds to residues 908 to 918
(Soltau et al., 2002). Mutation of these sites in Shank3 does not
interfere with tube formation (unpublished results). Taken to-
gether, our findings provide a molecular mechanism for the bi-
ological differences between Ret9 and Ret51 in epithelial tube
formation: Ret9 recruits the multiadaptor Shank3, and binding
of additional Grb2 protein is required for tubule formation.
 
Discussion
 
In this study we have identified the scaffolding adaptor
Shank3 as novel Ret9-binding partner, which interacts with a
newly identified PDZ-binding motif in the Ret9 isoform. We
also demonstrate that the Ret9 isoform, and not Ret51, is
able to induce the formation of tubular structures of kidney
epithelial cells in three-dimensional culture, and that this
ability is dependent on interaction with Shank3. Moreover,
the interaction of Shank3 with Ret9 is crucial for the sus-
tained activation of the Erk–MAPK and PI3K pathways
downstream of Ret9, both of which are required for the in-
duction of epithelial tubules.
Originally identified in neuronal cells (Boeckers et al.,
1999; Naisbitt et al., 1999; Tu et al., 1999; Yao et al., 1999),
Shank proteins are also expressed in other tissues such as in ep-
ithelial ducts of lung, pancreas, and kidney, and in hepatic bile
ducts (Redecker et al., 2001). In neuronal cells, Shank proteins
localize to postsynaptic densities and have been previously
shown to regulate dendritic spine morphology by linking the
postsynaptic signaling machinery to the cortical cytoskeleton
(Naisbitt et al., 1999; Tu et al., 1999; Sheng and Kim, 2000;
Sala et al., 2001; Boeckers et al., 2002). We demonstrate here
that Shank3 also has a defined biological role outside of neu-
ronal tissues, and that Shank3 actively participates in signal
Figure 6. The Ret9 PDZ-binding motif medi-
ates sustained Erk–MAPK and PI3K signaling.
MDCK cells, expressing Ret9 (a and e), Ret9
FA (b and f), Ret51 (c and g), or control cells
without Ret (d and h) were stimulated with
GDNF and sGFR1 and examined for Erk–
MAPK and Akt phosphorylation by SDS-
PAGE. Phosphorylated Erk1/2 (P-Erk1/2) or
Akt (P-Akt) proteins, total Erk2 and total Akt
were detected by Western blotting with spe-
cific antibodies. The specific bands for phos-
phorylated and unphosphorylated proteins
are indicated by arrows. Western blots were
quantified and activation levels over time are
shown. Error bars show standard deviation
from three independent experiments.
Figure 7. Shank3 interacts with Grb2. (a) Schematic representation of
the used Ret9 and Shank3 mutants. The consensus Grb2-binding motif
in Shank3 is underlined. (b) Interaction of Shank3 with endogenous
Grb2. HEK293 cells were cotransfected with Flag-tagged Shank3–Pro2
or Shank3–Pro2 containing the Y1006F mutant and Ret9, Ret9FA, or
Ret9Y1062F. Immunoprecipitation of Shank3 using Flag–M2 Sepha-
rose beads was performed followed by SDS-PAGE and Western blot-
ting. Western blots of immunoprecipitations and total lysates were de-
veloped with antibodies against Grb2, Flag, phospho-tyrosine (PY), and
Ret9 as indicated.
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transduction. Shank3 thus provides a platform for the regulated
recruitment of additional effectors, such as Grb2, that are
involved in stimulation of downstream signaling, although
Shank3 may still be involved in integration of receptor com-
plexes with the cytoskeleton. Other receptor tyrosine kinases,
for instance ErbB2, have been shown to harbor PDZ-binding
motifs, which interact with scaffold proteins (Maudsley et al.,
2000; Shelly et al., 2003). The PDZ protein ERBIN was de-
scribed initially to be important for the correct cellular localiza-
tion of ErbB2, but is now also known to participate in down-
stream signaling (Borg et al., 2000; Huang et al., 2003).
The kinetics of activation of the Erk–MAPK and PI3K
pathways is crucial for determining the biological outcome of
receptor tyrosine kinase signaling, e.g., increased migration
and differentiation of epithelial cells. From studies of the Met
receptor, it is known that sustained activation of Erk–MAPK
and PI3K signaling pathways is required for tubule formation,
whereas transient activation of these pathways is insufficient
to induce such morphological alterations (for review see Ro-
sario and Birchmeier, 2003). We show here that Shank3 func-
tion is required for sustained activation of both Erk–MAPK
and PI3K pathways downstream of Ret9. The central region of
Shank3 (aa 632–1057) is sufficient to mediate sustained acti-
vation of the Erk–MAPK and PI3K pathways and epithelial
tubule formation, and a newly identified Grb2-binding site
on Shank3 is essential for this activity. Interaction between
Shank3 and Grb2 is SH2 domain mediated and requires phos-
phorylation by Ret9. In contrast, binding of Grb2 to Ret9
through Shc or to Ret51 through an additional Grb2-binding
site (Besset et al., 2000) does not induce sustained activation
of the downstream pathways. Thus, Shank3 acts as a true scaf-
folding adaptor, which amplifies receptor tyrosine kinase sig-
naling. Shank-associated Grb2 may recruit Gab1 and Shp-2,
which are essential in tube formation (Maroun et al., 2000;
Schaeper et al., 2000; Rosario and Birchmeier, 2003). Shank
proteins may also serve to recruit additional signaling effec-
tors through the proline-rich and other tyrosine-containing se-
quences in the central domain. The biological functions of
these sites have not been determined. Shank3 is thus the first
isoform-specific Ret signaling effector. The isoform specific-
ity of the Ret–Shank interaction provides a molecular expla-
nation for the crucial role of Ret9 during mammalian kidney
development. Moreover, the Shank-binding site is conserved
in the Ret–PTC2 fusion protein found in human patients with
papillary thyroid carcinomas (Bongarzone et al., 1993), and
Shank proteins may therefore also be involved in the develop-
ment of Ret-induced tumors.
 
Materials and methods
 
Reagents and biochemical analysis
 
Antibodies to Ret9 (C-19-G), Ret51 (C-20), and c-Myc (A14-G) were pur-
chased from Santa Cruz Biotechnology Inc., antibodies to the extracellular
domain of Ret from R&D Systems, antibodies to active Erk–MAPK and Flag
tag from Sigma-Aldrich, antibodies to active Akt pS473 from Cell Signal-
ing, and anti–Akt-PKB
 

 
 and pan–Erk antibodies from BD Biosciences. Pro-
duction of rabbit anti–guinea pig antiserum against Shank3 was described
earlier (Bockmann et al., 2002). Antibodies were used at the following
concentrations: Ret9, Ret51, and PKB
 

 
, 1:500; pS473-Akt, c-Myc, and
Shank3, 1:1,000; pan-Erk, 1:2,000; and active Erk–MAPK, 1:5,000, for
Western blotting and Ret and Shank3, 1:50, for immunofluorescence; sec-
ondary antibodies were donkey anti–goat, goat anti–guinea pig or don-
key anti–rabbit IgG, which were conjugated with peroxidase, Cy2, or Cy3
(Jackson Laboratories). Erk–MAPK and PI3K Western blots were quantified
using TINA image analysis software (raytest Isotopengeraete GmbH). Point
mutations were introduced into Ret9 and Shank3 cDNAs using PCR or the
QuickChange site directed mutagenesis kit (Stratagene). Primers were
used as follows: Ret9 FA forward: CTCGCCTATGTGAGCGGTGGAGGC,
reverse: TTTTCAGCTGCTAGGCTCTAGTAAATGCATGTGAAATTCTACC;
Ret9 TY reverse: CATAGTCGACCTAGAATCTATAAAATGCATGTG; Ret9
YF reverse: TTTTCAGCTGCTAGGCTCTAGTAAATGCATGTGAAATTC-
TACCAAAGAGTTTG; Ret51-9 reverse: GATTGTCGACCTAGAATCTAG-
TAAATGCATGGCTATCAAATGTGTCC; Shank3-PDZ HV forward: GTC-
GTGAAGGTTGGAGTCAAG-CAAGTGGTGGGTCTC, reverse: GAGACC-
CACCACTTGCTTGACTCCA-ACCTTCACGAC; Shank3-Pro1 YF forward:
GGCCCTGATAGTCCCTTTGCCAACCTGGGCGCC, reverse: GGCGC-
CCAGGTTGGCAAAGGGACTATCAGGGCC. Expression of Ret and
Shank in MDCK cells was verified by RT-PCR using SuperScript II reverse
transcriptase (Invitrogen). Primers were used as follows: Ret9 and Ret9 FA
forward CAAGTGGATGGCAATTGAGTCC, reverse GTAAATGCATGT-
GAAATTCTACC; Ret51 and Ret51-9 reverse GTTAGCATATACACTAT-
CATTTGC; Ret9-Shank3-NT reverse GCAGGGTCGTCAATGCTC; Ret9-
Shank3-Pro1 reverse GCCGAGCACTATCCTCTG; Ret9-Shank3-Pro1 and
Ret9-Shank3-Pro1 YF reverse TCCAGTAGGGATGCCAGC; Shank3
forward CCGAAGCGGAAACTTTAC, reverse ACCCTTCCCTCCCA-
GAAACC. Human recombinant GDNF (TEBU) and sGFR
 

 
1 (R&D Systems)
were used at 25 ng/ml and 0.5 
 

 
g/ml, respectively. Yeast two-hybrid
analysis was performed as described previously (Weidner et al., 1996).
For coimmunoprecipitation, HEK293 cells were seeded at 3 
 

 
 10
 
6
 
 cells
per 10 cm dish and transfected using the calcium phosphate method. Cells
were lysed in Triton X-100 lysis buffer (1% Triton X-100, 20 mM Hepes, pH
7.5, 150 mM sodium chloride, and 10% glycerol) for 15 min, centrifuged
at 20,000 
 
g
 
 for 15 min and precipitated using Flag-M2–coupled Sepha-
rose (Sigma Aldrich) for 2 h at 4
 

 
C, followed by SDS-PAGE and Western
blotting. For coimmunoprecipitation of endogenous Shank3 and Ret9, two
adult mouse kidneys per immunoprecipitation were homogenized, lysed in
CHAPS lysis buffer (1% CHAPS, 10 mM Tris, pH 7.5, 10 mM sodium chlo-
ride), and centrifuged for 20 min at 4
 

 
C. The supernatant was incubated
with guinea pig anti-Shank3 antiserum for 2 h at 4
 

 
C before precipitation
with protein G–Sepharose. For Western blots of active Erk–MAPK and ac-
tive Akt, MDCK cells were seeded at 1.5 
 

 
 10
 
5
 
 per well on six-well dishes,
starved for 20 h in serum-free DMEM, stimulated with 50 ng/ml GDNF and
1 
 

 
g/ml sGFR
 

 
1, and lysed Triton X-100–containing lysis buffer.
 
Immunofluorescence and cell culture
 
Mouse embryos were dissected and fixed overnight in 4% formaldehyde.
For frozen sections, fixed embryos were rinsed with PBS, and embedded
in water soluble glycol’s and resins compound (Tissue-Tek O.C.T. com-
pound; Sakura Finetek). After acetone postfixation, sections were labeled
using anti-Shank3 antibody. Pictures were taken with a Zeiss Axiophot
Figure 8. Grb2 binding to Shank3 is required
for tubule formation. MDCK cells expressing
either Ret9–Shank3–Pro2 (a–c) or Ret–
Shank3–Pro2 containing the Y1006F mutation
(d–f) were examined for tubulogenesis in
three-dimensional collagen matrices. After
stimulation with GDNF–sGFR1 or HGF/SF,
cell cultures were fixed and photographed.
Bar in f: 200 m (applies to a–f). (g) Expres-
sion of the indicated cDNA constructs shown
by RT-PCR.
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fluorescence microscope using Zeiss 40
 

 
 F Fluar optics and a Diagnostic
Instruments SPOT-RT-Monochrome CCD camera. Contrast was adjusted us-
ing Adobe Photoshop imaging software.
MDCK cell lines were maintained in DMEM supplemented with
10% FCS, 100 IU/ml penicillin, and 100 mg/ml streptomycin at 37
 

 
C in
5% CO
 
2
 
. To generate stable MDCK cell lines, cells were transfected with
Lipofectamine 2000 (Invitrogen) and selected with 120 
 

 
g/ml G418 or
1.25 
 

 
g/ml Puromycin. HEK293 (human embryonic kidney 293) cells
and Neuro2A (mouse neuroblastoma 2A) cells were maintained in
DMEM, 10% FCS as for the MDCK cells, and transfected using the cal-
cium phosphate method. In the tubulogenesis assay, single MDCK cells
were embedded in a collagen type I solution containing 1.5 mg/ml Vitro-
gen 100 (Nutacon BV), 10% 10
 

 
 DMEM (Invitrogen), 10% FCS, 2.2 mg
ml NaHCO
 
3
 
, and 20 mM Hepes, pH 7.6. After gelation, medium was
added and cells were grown for 3–5 d until they formed cysts. Cells were
stimulated with GDNF and sGFR
 

 
1, or HGF/SF, and grown for 5–7 d fur-
ther before fixation in 4% formaldehyde. Pictures were taken with a Zeiss
Axiovert 135 microscope, using Zeiss 10
 
 
 
Achroplan optics and a Jenop-
tik ProgRes 3012mf camera. Pictures were deconvoluted manually by
stacking several images of different focus layers and reducing nonfocused
regions. Contrast was adjusted using Adobe Photoshop imaging software.
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